Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07513116) titled 'Evaluating Intermittent Fasting In Individuals At High Risk ForPancreatic Cancer Undergoing Screening' on April 1.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: None (Open Label).
Primary Sponsor: M.D. Anderson Cancer Center
Condition:
Evaluating
Intermittent Fasting
Pancreatic Cancer
Intervention:
Other: intermittent fasting
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: September 17, 2026
Target Sample Size: 20
Countries of Recruitment:
United States
To know more, visit https://clinica...